by AMERSA
We hope that you have had time to go through all of this issue’s Author’s Own Words! This was a special issue of SAj, almost all of the manuscripts highlighted Addressing Opioid Misuse through Healthcare Provider Training.
The most viewed manuscript in this issue was:
Adam J. Gordon, MD, MPH & John Daniel Harding Jr., BA
With 2,058 views…and counting!
Make sure to follow us on twitter to stay up to date with SAj.
by AMERSA
The Authors’ Own Words: We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Mary M. Ramos, MD, MPH; Rachel A. Sebastian, MA; Mary Murphy, BS; Kristin Oreskovich, PNP; & Timothy P. Condon, PhD
Substance Abuse Vol. 38, Iss. 2, 2017
“This 2015 statewide school-based health center (SBHC) workforce survey found high levels of perceived role responsibility, self-efficacy, confidence, and comfort around addressing substance use among primary care and behavioral health care SBHC providers. However, less than half of providers reported practicing the full Screening, Brief Intervention and Referral to Treatment (SBIRT) model at their SBHC. SBHC provider attributes including role responsibility, self-efficacy, confidence, and comfort were all significantly associated with the provision of SBIRT. These findings suggest that continuing education on SBIRT as well as trainings to enhance these provider attributes (including role responsibility and self-efficacy) may help increase the uptake of SBIRT in SBHC settings.”
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!
by AMERSA
The Authors’ Own Words: We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
What Do Physicians Want to Know About Opioid Prescribing? A Qualitative Analysis of Their Questions
Phoebe A. Cushman, MD; Jane M. Liebschutz, MD, MPH; Joseph G. Hodgkin, BA; Christopher W. Shanahan, MD, MPH; Julie L. White, MS; Ilana Hardesty, BA; & Daniel P. Alford, MD, MPH
Substance Abuse Vol. 38, Iss. 2, 2017
“The primary contribution of this study is a qualitative analysis of how well the FDA’s extended release/long acting (ER/LA) opioid analgesic Risk Evaluation and Mitigation Strategy (REMS) curricular Blueprint addresses the concerns of opioid prescribers who attended a REMS training. The study found that providers are eager to learn not only the mechanics of safe opioid prescribing for chronic pain (e.g. risk assessments, patient-provider agreements), but also how to have challenging discussions with patients about opioids while maintaining a positive patient-provider relationship. Other important findings included prescribers’ requests for information on safe alternatives to opioids and frustration with the lack of access to pain specialists. A major implication of our study is that all providers need improved instruction in comprehensive pain management across their careers. The FDA curricular Blueprint is continually being revised and updated; we believe that future updates should address providers’ additional concerns.”
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!
by AMERSA
The Authors’ Own Words: We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Emily E. Hurstak, MD, MPH; Margot Kushel, MD; Jamie Chang, PhD; Rachel Ceasar, PhD; Kara Zamora, MA; Christine Miaskowski, RN, PhD, FAAN; & Kelly Knight, PhD
Substance Abuse Vol. 38, Iss. 2, 2017
“In our qualitative study, found that both PCPs and patients emphasized medico-legal risks of opioids to the prescribing clinician. Patients minimized adverse health consequences of opioids. However, patients did report a risk of addiction, which they defined differently than clinicians. Patients perceived clinic policies aimed at reducing opioid misuse to be stigmatizing and applied unfairly. Our findings have implications for the informed consent process for chronic opioid therapy, the implementation of clinical opioid prescribing policies, and the use of overdose prevention strategies like naloxone.”
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!
by AMERSA
The Authors’ Own Words: We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Suzanne Carlberg-Racich, MSPH, PhD & Lindsey Roden, MPH
Substance Abuse Vol. 38, Iss. 2, 2017
“Creating a collaborative patient-provider relationship is critical to facilitating healthy patient outcomes and mitigating the risk of provider burnout. HIV-positive, African-American patients who use drugs face additional barriers in creating and maintaining a collaborative relationship with their providers. This research exposes both patient and provider-level barriers to provide a conceptual framework of the HIV care visit. This framework may serve as a foundation for addressing critical barriers and integrating patient-centered care, to promote positive outcomes.”
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!
